Amanda Crowson, MPH, RN, CPH, CIC, is a highly accomplished infection preventionist at AdventHealth Tampa that has been recognized for her research on implementing perineal care practices to minimize the occurrence of catheter-associated urinary tract infections (CAUTIs).
Patricia Jackson, BSN, RN, CIC, FAPIC, 2023 President of APIC and Devin Jopp, EdD, MS, CEO of APIC spoke to a group of reporters, including Infection Control Today about exciting and encouraging new strategies to further the IPC profession.
To celebrate 40 years, the Certification Board of Infection Control and Epidemiology wants to showcase the certification milestones on their website.
Infection preventions across the United States and the world converge at the annual APIC conference to learn the newest information on IPC. Read this article on who else should go to learn how to prevent and control infections.
Infection Control Today speaks with the CEO of Blue Water Biotech about how to get around antimicrobial resistance and why there may not be a need for more antibiotic creation.
Lifetime's new short film educates viewers on preventing meningitis B, which can cause the devastating loss of loved ones and features Soleil Moon Frye and Melissa Joan Hart.
Are you attending the 2023 APIC Conference in Orlando, Florida, from June 26-28? Check out this list to see the best things to do while you’re in town!
Vaccitech, a biopharmaceutical company, has created a vaccine named VTP-300. They are currently showcasing positive initial results through a poster presentation at the ongoing European Association for the Study of the Liver (EASL) Congress 2023.
In this third installment of the interview, managers at Sage Memorial Hospital describe how the OhmniLab robots have become part of their team, complete with Navajo names.
Karen Hoffmann, MS, RN, CIC, FSHEA, FAPIC, will be honored with the Carole DeMille Achievement Award during the 2023 APIC conference in Orlando, Florida, held June 26 to 28, 2023. She also discusses the poster she will be presenting.
As more and more residents in long-term care facilities get Candida auris, infection preventionists must know how to prevent, prepare for, and control a C auris outbreak. An expert explains how.
Rates of health care-associated infections rose during the COVID-19 pandemic. Investigators have found that often the infections came from the patients themselves. But how?
Because of the COVID-19 pandemic, the infection prevention field had to think outside the box they were used to. The Navajo Nation was no different. Outside their box, they found UV-C robots.
The recent increase in drug-resistant strains of Candida auris, causing mortality at rates as high as 60%, raises questions regarding the spread of this pathogen as a health care-associated infection, cleaning/disinfecting protocol, and treatment via antifungal drugs.
SSI surveillance tracks infections that occur after surgery in the area where it was performed. How can facilities help prevent these infections?
An outbreak investigation in the American Journal of Infection Control reviews the infection control procedures implemented by an academic medical center in response to a patient's introduction of scabies to health care workers.
The FDA released a draft guideline for creating and distributing tattoo inks to prevent microorganisms from tainting the inks and causing severe infections. They are asking for input.
Investigators studied the risk factors for surgical site infections after abdominal hysterectomy procedures using NHSN data and diagnosis codes from administrative data.
Although older adults have 2 vaccines, this would be the first vaccine or antiviral option for infants.
What is the CDC's Antimicrobial Resistance Funding map? A key opinion leader explains.
Listen to how a doctor in rehabilitation who works with patients with brain and neurologic injuries is now working with patients with long COVID.
COVID-19, schools, and children are sensitive topics. Some worry about transmission in schools, while others don't see it as a concern. Which is it?
A recent study published in the Journal of Hepatology aimed to determine the likelihood of parenterally transmitted hepatitis after invasive medical procedures in Italy.
Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending June 4, 2023.
The FDA's decision to approve Abrysvo was based on data from a Phase 3 clinical trial, RENOIR, demonstrating the RSV vaccine's efficacy, immunogenicity, and safety in adults 60 and older.
